Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A review by the respected Cochrane organisation, and led by Oxford University Professor of Psychiatry Keith Hawton, has found that psychological therapies, more commonly known as 'talking treatments', may help people who self-harm.

Self-harm is intentional self-poisoning or self-injury. Many people who are admitted to hospital because of this are at an increased risk of self-harming again and of suicide.  It is a major problem in many countries, leads to high levels of distress for patients and their families and friends, and places significant demands on health services.

Psychosocial interventions could involve specific psychological therapies as well as maintaining support and contact with patients.  Psychological therapies are usually a type of 'talking treatment'. Cognitive Behavioural Therapy (CBT), a specific type of psychological therapy, focuses on how a patient's beliefs and attitudes affect their feelings and behaviour, and aims to help them respond to and deal with their problems.

Read more

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.